论著
ENGLISH ABSTRACT
TW-37调节NF-κB信号通路抑制体外胰腺癌细胞转移的实验研究
吴隆超
王琳娜
刘瑞东
王晓丽
田文霞
李兴涛
张俊
作者及单位信息
·
DOI: 10.3760/cma.j.issn.1674-1935.2016.04.006
TW-37 inhibited metastasis in pancreatic cancer via regulating NF-κB signal in vitro
Wu Longchao
Wang Linna
Liu Ruidong
Wang Xiaoli
Tian Wenxia
Li Xingtao
Zhang Jun
Authors Info & Affiliations
Wu Longchao
Departnent of General Surgery, People′s Hospital of Penglai, Penglai 265600, China
Wang Linna
Liu Ruidong
Wang Xiaoli
Tian Wenxia
Li Xingtao
Zhang Jun
·
DOI: 10.3760/cma.j.issn.1674-1935.2016.04.006
0
0
0
0
0
0
PDF下载
APP内阅读
摘要

目的观察TW-37干预对胰腺癌细胞增殖、凋亡、侵袭及血管生成的影响,探讨其可能机制。

方法应用TW-37干预胰腺癌细胞株BxPC3和HPAC,以转染NF-κB p65 cDNA(p65 cDNA)、靶向NF-κB p65的siRNA(siRNA-p65)细胞及未干预细胞作为对照组。采用MTT和ELISA法检测细胞增殖和细胞凋亡;应用Transwell小室检测细胞侵袭能力;采用体外人脐静脉内皮细胞(HUVECs)成管实验观察细胞培养上清对血管生成的影响;ELISA法检测细胞NF-κB活性;蛋白质印迹法检测细胞NF-κB靶向调节蛋白VEGF、MMP-9表达。

结果TW-37呈浓度和时间依赖性抑制BxPC3、HPAC细胞的增殖,诱导两株细胞的凋亡( A 405值1.29±0.21比0.09±0.01,1.07±0.18比0.08±0.01),抑制细胞NF-κB活性及NF-κB p65、VEGF、MMP-9蛋白表达,差异均有统计学意义( P值均<0.05)。对照组、0.75 μmol/L TW-37干预组的穿膜细胞数分别为(46.7±5.24)、(10.3±1.26)个/200倍视野;HUVECs形成的血管数分别为(39.4±4.36)、(7.84±1.25)个/200倍视野,差异均有统计学意义( P值均为0.001)。转染p65 cDNA的两株细胞的NF-κB活性较对照组显著增加,用TW-37干预后NF-κB活性下降;转染siRNA-p65的两株细胞的NF-κB活性较对照组显著下降,用TW-37干预后NF-κB活性进一步下降,差异均有统计学意义( P<0.05或<0.01)。转染p65 cDNA对两株细胞凋亡无明显影响,用TW-37干预后凋亡略有变化;转染siRNA-p65的两株细胞凋亡显著增加,用TW-37干预后又进一步增加,差异均有统计学意义( P值均<0.01)。

结论TW-37通过NF-κB抑制胰腺癌细胞增殖、侵袭和血管生成,诱导细胞凋亡。

胰腺肿瘤;生长;肿瘤转移;病理性血管生成;TW-37
ABSTRACT

ObjectiveTo study the effect and mechanisms of TW-37 on cell proliferation, apoptosis, invasion and angiogenesis in pancreatic cancer cells in vitro and further explore the potential mechanism.

MethodsBxPC3 and HPAC cells were pretreated with TW-37 using untransfected or transfected with NF-κB p65 cDNA(p65 cDNA)or NF-κB p65 siRNA(siRNA-p65)cells as controls. Cell viability was determined by MTT assay. Cell apoptosis was assessed by enzyme-linked immunosorbent assay (ELISA). Cell invasion and angiogenesis was detected by Transwell and endothelial tube formation assay of HUVECs. ELISA assay was used to measure the activity of NF-κB, and its target proteins of MMP-9 and VEGF were detected by western blot.

ResultsTW-37 suppressed cell growth and induced apoptosis (A405: 1.29±0.21 vs 0.09±0.01, 1.07±0.18 vs 0.08±0.01), inhibited NF-κB activity and protein expression of NF-κB p65, VEGF and MMP-9(all P<0.05)in a dose- and time-dependent manner. The number of cells that invaded across the matrigel in the transwell chamber was (46.7±5.24) and (10.3±1.26)/×200 in BxPC3 control and 0.75 μmol/L TW-37 group ( P=0.001). The number of tube formation was (39.4±4.36) and (7.84±1.25)/×200, ( P=0.001). NF-κB activity was increased by p65 cDNA transfection, and decreased by TW-37 treatment in both of the two cell lines ( P<0.05). However, NF-κB activity was decreased by p65 siRNA transfection, and greatly decreased by TW-37 treatment in both two cell lines ( P<0.05 or P<0.01). Transfection of p65 cDNA did not significantly affect cell apoptosis. Transfection of p65 siRNA increased cell apoptosis, and greatly increased by TW-37 treatment in both two cell lines (all P<0.01).

ConclusionsTW-37 could inhibit the proliferation, invasion and angiogenesis in pancreatic cancer cells by regulating NF-κB signal pathway.

Pancreatic neoplasms;Growth;Neoplasm metastasis;Neovascularization, pathologic;TW-37
Zhang Jun, Email: mocdef.6ab21jngnaixnay
引用本文

吴隆超,王琳娜,刘瑞东,等. TW-37调节NF-κB信号通路抑制体外胰腺癌细胞转移的实验研究[J]. 中华胰腺病杂志,2016,16(4):237-242.

DOI:10.3760/cma.j.issn.1674-1935.2016.04.006

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
胰腺癌是极易侵袭和转移的恶性肿瘤,传统的治疗手段疗效差,因此基因治疗胰腺癌是目前研究的热点 [ 1 ]。Bcl-2在胰腺癌组织过度表达,激活NF-κB,发挥抗凋亡和促胰腺癌细胞转移作用 [ 2 , 3 ]。文献报道 [ 4 ],应用RNA干扰技术抑制胰腺癌细胞Bcl-2表达能显著抑制胰腺癌细胞的生长和侵袭能力,提示Bcl-2可能是胰腺癌基因治疗的有效靶点。TW-37是近年来发现的Bcl-2的小分子抑制剂,它对多种肿瘤细胞的生长和转移都有明显的抑制作用 [ 5 ]。本研究观察TW-37对胰腺癌细胞生长、转移和血管生成的影响,探讨TW-37的作用机制。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Chiorean EG , Coveler AL . Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies[J]. Drug Des Devel Ther, 20159(7):3529-3545. DOI: 10.2147/DDDT.S60328 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Garcea G , Neal CP , Pattenden CJ ,et al. Molecular prognostic markers in pancreatic cancer: a systematic review[J]Eur J Cancer, 200541(15):2213-2236.
返回引文位置Google Scholar
百度学术
万方数据
[3]
Fahy BN , Schlieman MG , Mortenson MM et al. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib[J]Cancer Chemother Pharmacol, 2005,56(7):46-54.
返回引文位置Google Scholar
百度学术
万方数据
[4]
Okamoto K , Murawaki Y The therapeutic potential of RNA interference: novel approaches for cancer treatment[J]Curr Pharm Biotechnol, 201213(11):2235-2247.
返回引文位置Google Scholar
百度学术
万方数据
[5]
Masood A Azmi AS Mohammad RM . Small molecule inhibitors of bcl-2 family proteins for pancreatic cancer therapy[J]Cancers, 20113(2):1527-1549. DOI: 10.3390/cancers3021527 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
Ansari D , Rosendahl A , Elebro J ,et al. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer[J]Br J Surg, 2011,98(8):1041-1055. DOI: 10.1002/bjs.7574 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Mortenson MM , Galante JG , Gilad O ,et al. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer[J]J Cell Biochem, 2007102(5):1171-1179.
返回引文位置Google Scholar
百度学术
万方数据
[8]
Wang H , Zhang Z , Wei X ,et al. Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells[J]J Ovarian Res, 20158(1):3-8. DOI: 10.1186/s13048-015-0130-x .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Ashimori N , Zeitlin BD , Zhang Z ,et al. TW-37, a small-molecule inhibitor of Bcl-2, mediates S-phase cell cycle arrest and suppresses head and neck tumor angiogenesis[J]Mol Cancer Ther, 20098(4):893-903DOI: 10.1158/1535-7163.MCT-08-1078 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Mortenson MM , Galante JG , Gilad O ,et al. BCL-2 functions as an activator of the NF-kappaB signaling pathway in pancreatic cancer[J]. J Cell Biochem, 20071021171-1179.
返回引文位置Google Scholar
百度学术
万方数据
[11]
Al-Katib AM , Sun Y , Goustin AS et al. SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status[J]J Hematol Oncol, 200916(2):8-16. DOI: 10.1186/1756-8722-2-8 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Azmi AS , Wang Z , Burikhanov R et al. Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis[J]Mol Cancer Ther, 20087(9):2884-2893.
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
张俊,Email: mocdef.6ab21jngnaixnay
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号